240 related articles for article (PubMed ID: 3494282)
1. The pharmacologic control of mediator release from human basophils and mast cells.
Peters SP; Naclerio RM; Schleimer RP; MacGlashan DW; Pipkorn U; Lichtenstein LM
Respiration; 1986; 50 Suppl 2():116-22. PubMed ID: 3494282
[TBL] [Abstract][Full Text] [Related]
2. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
Eggleston PA; Kagey-Sobotka A; Proud D; Adkinson NF; Lichtenstein LM
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):960-4. PubMed ID: 1691604
[TBL] [Abstract][Full Text] [Related]
3. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
4. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.
Heavey DJ; Ernst PB; Stevens RL; Befus AD; Bienenstock J; Austen KF
J Immunol; 1988 Mar; 140(6):1953-7. PubMed ID: 2450136
[TBL] [Abstract][Full Text] [Related]
5. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.
Schleimer RP; Schulman ES; MacGlashan DW; Peters SP; Hayes EC; Adams GK; Lichtenstein LM; Adkinson NF
J Clin Invest; 1983 Jun; 71(6):1830-5. PubMed ID: 6134755
[TBL] [Abstract][Full Text] [Related]
6. Characterization of inflammatory mediator release from purified human lung mast cells.
Schleimer RP; MacGlashan DW; Peters SP; Pinckard RN; Adkinson NF; Lichtenstein LM
Am Rev Respir Dis; 1986 Apr; 133(4):614-7. PubMed ID: 3485946
[TBL] [Abstract][Full Text] [Related]
7. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
Triggiani M; Giannattasio G; Balestrieri B; Granata F; Gelb MH; de Paulis A; Marone G
Clin Exp Allergy; 2004 Feb; 34(2):241-9. PubMed ID: 14987304
[TBL] [Abstract][Full Text] [Related]
8. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
Undem BJ; Peachell PT; Lichtenstein LM
J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
Marone G; Columbo M; Galeone D; Guidi G; Kagey-Sobotka A; Lichtenstein LM
Agents Actions; 1986 Apr; 18(1-2):100-2. PubMed ID: 2425566
[TBL] [Abstract][Full Text] [Related]
10. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
Marone G; Cirillo R; Genovese A; Marino O; Quattrin S
Life Sci; 1989; 45(19):1745-54. PubMed ID: 2480501
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin.
Marone G; Columbo M; Triggiani M; Cirillo R; Genovese A; Formisano S
Biochem Pharmacol; 1987 Jan; 36(1):13-20. PubMed ID: 2432900
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.
Schulman ES; Post TJ; Henson PM; Giclas PC
J Clin Invest; 1988 Mar; 81(3):918-23. PubMed ID: 2449462
[TBL] [Abstract][Full Text] [Related]
13. Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins.
Wells E; Harper ST; Jackson CG; Mann J; Eady RP
J Immunol; 1986 Dec; 137(12):3933-40. PubMed ID: 2431048
[TBL] [Abstract][Full Text] [Related]
14. Mediator release from human basophils and mast cells from lung and intestinal mucosa.
Fox CC; Kagey-Sobotka A; Schleimer RP; Peters SP; MacGlashan DW; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1985; 77(1-2):130-6. PubMed ID: 2409011
[No Abstract] [Full Text] [Related]
15. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
16. Purified human basophils and mast cells: current concepts of mediator release.
Schulman ES; MacGlashan DW; Schleimer RP; Peters SP; Kagey-Sobotka A; Newball HH; Lichtenstein LM
Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():53-61. PubMed ID: 6578086
[TBL] [Abstract][Full Text] [Related]
17. Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells.
Marone G; Columbo M; de Paulis A; Cirillo R; Giugliano R; Condorelli M
Agents Actions; 1986 Apr; 18(1-2):103-6. PubMed ID: 2425567
[TBL] [Abstract][Full Text] [Related]
18. Control mechanisms of mediator release in human basophils and mast cells.
Marone G
Immunol Invest; 1988; 17(8-9):707-45. PubMed ID: 2465995
[No Abstract] [Full Text] [Related]
19. Mediator release from human lung under conditions of reduced oxygen tension.
Peters SP; Lichtenstein LM; Adkinson NF
J Pharmacol Exp Ther; 1986 Jul; 238(1):8-13. PubMed ID: 2425080
[TBL] [Abstract][Full Text] [Related]
20. The pharmacologic modulation of the release of arachidonic acid metabolites from purified human lung mast cells.
Peters SP; MacGlashan DW; Schleimer RP; Hayes EC; Adkinson NF; Lichtenstein LM
Am Rev Respir Dis; 1985 Aug; 132(2):367-73. PubMed ID: 3927806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
